The mission of the Neurofibromatosis Therapeutic Acceleration Program (NTAP) is to identify and develop new therapies for Neurofibromatosis Type 1 associated tumors. NTAP currently partners with more than 40 academic, government and private organizations to conduct NF1 associated research.
Specific duties & responsibilities:
Reporting to the Executive Director, the Program Director will be responsible for the development of new clinical scientific and clinical operational initiatives for NTAP, the review / critique of ongoing clinical research initiatives, overseeing data and data analysis in collaboration with data analysis partners such as Sage Bionetworks and facilitating clinical collaborations among the neurofibromatosis type 1 (NF1) clinical research community within and outside of NTAP.
Oversee contractor / awardee resources to ensure clinical trial success, and for ensuring that all team members comply with relevant regulations, guidance’s, directives and standards. Ensure operationalization and execution of clinical trials including; adherence to all regulations and guidelines, agreements and scope of work and change orders.
Represent NTAP externally, by preparing and delivering presentations about NTAP initiatives, assisting with scientific reports, building new scientific partnerships and working closely with NTAP’s key scientific partners. External collaborations could include things such as involvement in the non-disclosure agreement process with corporations and new partners.
Have a clear understanding of the drug development process (especially early phase clinical trials), protocol writing & study conduct, the principles of translational medicine and how to work effectively within cross-functional teams ensuring their success. We are seeking a well-trained clinical scientist/clinician with an entrepreneurial spirit and strong leadership skills who is driven by science and the desire to develop novel therapies for patients.
For more information and to apply, please visit https://jobs.jhu.edu/job/Baltimore-Program-Director-MD-21287/473351700/